Involuntary Movement Disorders in Central Nervous System Fungal Infections: A Systematic Review
Movement Disorders Clinical Practice · 2026-04 · 13 (4) · 889-894
DOI: 10.1002/mdc3.70403 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 22.10.2025. Verfasst von Ravindra Kumar Garg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, India. Hauptthemen laut MEDLINE: Central Nervous System Fungal Infections, Movement Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Central nervous system fungal infections, though rare, may lead to various movement disorders either due to direct fungal invasion or as adverse effects of antifungal drugs.
Objectives
This systematic review aimed to consolidate all published cases and characterize the clinical patterns, mechanisms, and outcomes.
Methods
A systematic review was conducted in line with PRISMA 2020 guidelines and registered with PROSPERO (CRD420251088348). Published case reports, series, and cohorts describing movement disorders in CNS fungal infections were identified from PubMed, EMBASE, Scopus, and Google Scholar.
Results
Forty‐five studies with 50 cases were included. Movement disorders directly attributed to fungal infection ( n = 22; 44%) occurred predominantly in males (86.4%) with a mean age of 48 years. The most common pathogens were Cryptococcus neoformans (68.2%) and Coccidioides (13.6%). Chorea (45.5%), parkinsonism (27.3%), and tremor (13.6%) were frequent. Basal ganglia involvement was seen in 77.3% of patients. Antifungal drugs used included amphotericin B (77.3%), fluconazole (50%), and flucytosine (54.5%). Outcomes included full recovery (18.2%), partial improvement (36.4%), persistent symptoms (22.7%), and death (22.7%). Drug‐induced movement disorders ( n = 11; 22%) were linked mainly to amphotericin B (81.8%), with tremor (45.5%), myoclonus (18.2%), and dystonia (18.2%). Mortality was 45.5%. Ataxia with cerebellar involvement ( n = 17; 34%) presented as gait (58.8%), truncal (29.4%), or limb ataxia (17.6%), with cerebellar abscesses (52.9%) and leptomeningeal enhancement (23.5%) on imaging. Recovery occurred in 64.7%, while 17.6% died.
Conclusion
CNS fungal infections can lead to diverse variety of movement disorders. Early recognition of clinical patterns and neurotoxic drug effects is essential for optimal management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, India.
- Department of Neurology, King George's Medical University, Lucknow, India.
- Department of Pulmonary Medicine, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India.
- Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Ravindra Kumar Garg, Raza Abbas Mahdi
Zitieren
APA
Garg, R. K., Pandey, S., Singhal, S., & Mahdi, R. A. (2026). Involuntary Movement Disorders in Central Nervous System Fungal Infections: A Systematic Review. Movement Disorders Clinical Practice, 13(4), 889-894. https://doi.org/10.1002/mdc3.70403
Vancouver
Garg RK, Pandey S, Singhal S, Mahdi RA. Involuntary Movement Disorders in Central Nervous System Fungal Infections: A Systematic Review. Movement Disorders Clinical Practice. 2026;13(4):889-894. doi:10.1002/mdc3.70403
BibTeX
@article{Garg2026,
author = {Garg, Ravindra Kumar and Pandey, Shweta and Singhal, Sanjay and Mahdi, Raza Abbas},
title = {Involuntary Movement Disorders in Central Nervous System Fungal Infections: A Systematic Review},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {4},
pages = {889--894},
doi = {10.1002/mdc3.70403}
}
EUVIMED